Can colloidal silver help heal or stop the progress of eyesight diseases, such as macular degeneration?

One lady, a registered nurse, is convinced that silver is dramatically helping her 77 year old husband who had been diagnosed two and a half years ago with Age-Related Macular Degeneration. She says the degeneration of his eyesight has not progressed at all since she started putting two drops of colloidal silver into each of his eyes daily.

We’ll take a quick look at her story. And we’ll also take a look at a recent clinical study into silver’s effectiveness against retinal angiogenesis, which can lead to Age-Related Macular Degeneration and ultimately to blindness. And we’ll see why many researchers are now calling nanosilver “a trove for retinal therapies”…

Interesting experience using colloidal silver in the eyes


Can colloidal silver help heal or stop the progress of eyesight diseases?- google image

Here’s what reader Marie P., a registered nurse, wrote about her rather interesting experience using colloidal silver in the eyes of her 77 year old husband who has been diagnosed with age-related macular degeneration:

“Two 1/2 years ago my 77 year old husband was diagnosed with Age Related Macular Degeneration.

Doctor told him to start taking OTC AREDS 2, which is pricey, and return in 6 months. [Editor’s note: OTC AREDS is an over-the-counter multi-vitamin and mineral formula for the eyes, used by people with macular degeneration.]

Just before the 6 months was up, I decided to start putting 2 drops of colloidal silver in each eye every pm. He went for the 6 month checkup while we continued the silver.

When he returned in 6 more months, there was no change and he had to return in a year. He went two days ago for that checkup, and again STILL NO CHANGE! Dr. told him to continue AREDS 2. My husband told him he had not taken it in over a year!

Now, you’ve got to admit, that’s a fascinating testimonial. Of course, I have to warn you upfront that testimonials are not “proof” of effectiveness for any medical condition. Only clinical studies constitute proof. And truth be told, there’s very little published clinical research on using colloidal silver for eyesight diseases.

Clinical studies 


Naturally, more research is needed on this subject- google image

However, there is a very interesting overview of clinical studies on the use of nanosilver in the eyes. This overview was published in 2016 in the Journal of Controlled Release, and titled Silver Nano – a Trove for Retinal Therapies.

In that study overview researchers looked at using silver nanoparticles as a treatment for an eyesight condition known as pathological retinal angiogenesis (aka retinal neovascularization) consisting of abnormal growth of blood vessels in the eyes which ultimately leads to irreversible blindness.

What the researchers discovered was that applying nanosilver to the eyes reduced the downstream signaling pathways that lead to retinal angiogenesis. In other words, it helped halt the progression of the condition which otherwise would lead to blindness.

The researchers stated “Gaining the ability to control retinal angiogenesis does not only benefit clinical therapy, but also has an enormous scientific appeal.” They went on to say:

“Silver nanoparticles due to their potent characteristics such as anti-permeability, anti-tubules formation, anti-vasculature development, bear out them as an effective molecule in inhibiting angiogenesis and also capable of inducing apoptosis by altering the caspase-3 activity leading DNA fragmentation…”

In other words, clinical testing has demonstrated that nanosilver has the ability to inhibit the process called angiogenesis in which abnormal blood vessels form in front of the retina, blocking vision, which ultimately leads to blindness in people afflicted with it.

And the silver also causes abnormal blood cells from retinal angiogenesis to go into a state of apoptosis (i.e., cellular suicide) so they can no longer spread over the eye.

The researchers concluded:

“Our studies on the effect of silver nanoparticles over angiogenesis make a significant impact in treating common causes of blindness such as PDR [i.e. proliferative diabetic retinopathy] and AMD [i.e., age-related macular degeneration].

Further studies on size controlled effect of silver nanoparticles and other down streaming pathways, by which they themselves act as a drug, by controlled release and targeting, will surely signify the role of silver nanoparticles for effective and economic treatments in ocular therapies.”

The researchers concluded their research by stating their belief that the use of silver nanoparticles will make a “significant impact” on the treatment of common causes of blindness such as Proliferative Diabetic Retinopathy and Age-Related Macular Degeneration.

So there you have it.

A small handful of anecdotal accounts suggest (but do not prove) that just a few drops of colloidal silver used in the eyes daily can help stop the progression of Age-Related Macular Degeneration. And at least some clinical research backs up that assertion, particularly where it pertains to Age-Related Macular Degeneration caused by pathological retinal angiogenesis, or abnormal blood cell formation over the retina.

The researchers behind this study even call nanosilver a “trove for retinal therapies” in the title of their clinical overview, and a “boon to ocular therapies” in their abstract!

Naturally, more research is needed on this subject. For example, there’s not been enough research conducted to determine how long one can safely put silver into one’s eyes without experiencing side effects. Nor has a correct daily dosage yet been determined from clinical research.

But it’s extremely exciting to see this development taking place, clinically, because the preliminary research demonstrates silver to be a viable treatment for one of the leading causes of blindness in developed countries, which is pathological retinal angiogenesis, otherwise known as retinal revascularization.


Leave a comment

Item added to cart.
0 items - VND0